Search - tctmd.com

Displaying 221 - 240 of 475

Sort: Relevancy | Date

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Presenter: Stephen G. Ellis, Patrick W. Serruys

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Presenter: Michael C. John, Gregg W. Stone, Chuck Simonton

November 01, 2016

Presentation TCT 2016

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Christoph K. Naber

November 01, 2016

Presentation TCT 2016

FDA Perspectives on Short DAPT IDE Trials

Presenter: Michael C. John, Gregg W. Stone, Andrew Farb

November 01, 2016

Presentation TCT 2016

BRS Benchtop Findings: Implications for Implantation Techniques

Presenter: Stephen G. Ellis, Patrick W. Serruys, Nicolas Foin

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber

November 01, 2016

Presentation TCT 2016

FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds

Presenter: Michael C. John, Gregg W. Stone, P.F. Adrian Magee

November 01, 2016

Presentation TCT 2016

Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Michael Haude

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Presenter: Sanjay Kaul, Jeffrey J. Popma, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

Presenter: Gregg W. Stone, Ron Waksman, Vasim Farooq

November 01, 2016

Presentation TCT 2016

TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with Bioresorbable Scaffolding Platforms in Europe) Registry

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

Back to BRS: Falcon, the Next Generation

Presenter: Ron Waksman, Robert-Jan van Geuns, Richard J. Rapoza

October 31, 2016

Presentation TCT 2016

BRS Snapshots: A Novel Biodegradable FE/316L Stent

Presenter: Ron Waksman, Robert-Jan van Geuns, Olivier F. Bertrand

October 31, 2016

Presentation TCT 2016

BRS Snapshots: Lifetech Iron-Based BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Runlin Gao

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ArterioSorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

BRS Snapshots: The Biolute BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Dinesh Shah

October 31, 2016

Presentation TCT 2016

BRS Snapshots: XINSORB

Presenter: Ron Waksman, Robert-Jan van Geuns, Lei Ge

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

Presenter: Ron Waksman, Robert-Jan van Geuns, Antoine Lafont

October 31, 2016

Advertisement

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided?

FDA Perspectives on Short DAPT IDE Trials

BRS Benchtop Findings: Implications for Implantation Techniques

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds

Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli and More

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI!

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with Bioresorbable Scaffolding Platforms in Europe) Registry

Back to BRS: Falcon, the Next Generation

BRS Snapshots: A Novel Biodegradable FE/316L Stent

BRS Snapshots: Lifetech Iron-Based BRS

BRS Snapshots: ArterioSorb

BRS Snapshots: The Biolute BRS

BRS Snapshots: XINSORB

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content